STOCK TITAN

MAXIMUS (MMS) Stock News, Nov 2024-Apr 2025

MMS NYSE

Maximus, Inc. reports developments tied to its role as a provider of tech-enabled government services for public programs. The company supports government agencies with business process management, technology solutions, health insurance eligibility and enrollment programs, clinical services, assessments, appeals and independent medical reviews across U.S. Federal Services, U.S. Services and international operations.

Recurring news includes fiscal results, guidance updates, sales-pipeline commentary, segment trends, clinical program demand and productivity initiatives. Company updates also cover AI-enabled tools such as Accuracy Assistant for state SNAP programs, quarterly cash dividends, common-stock repurchase authorizations and governance changes involving senior legal and corporate-secretary roles.

Rhea-AI Summary

Maximus (NYSE: MMS), a leading provider of government services worldwide, has announced a quarterly cash dividend of $0.30 per share. The dividend was approved by the Board of Directors on April 5, 2025, and will be payable on May 31, 2025, to shareholders of record on May 15, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.91%
Tags
dividends
-
Rhea-AI Summary

Maximus (NYSE: MMS) reported strong Q1 FY2025 results with revenue increasing 5.7% to $1.40 billion, driven by 6.3% organic growth primarily from U.S. Federal Services. Diluted EPS was $0.69 and adjusted diluted EPS reached $1.61, compared to $1.04 and $1.34 in the prior year.

The company raised its FY2025 guidance, expecting adjusted EBITDA margin of 11.2% and adjusted diluted EPS between $5.90-$6.20. Revenue guidance was adjusted to $5.2-$5.35 billion following recent divestitures. During Q1, Maximus purchased 3.1 million shares for $237 million, with additional 0.7 million shares bought for $52.9 million after quarter-end.

U.S. Federal Services revenue grew 15.3% to $780.7 million, while U.S. Services revenue decreased 7.7% to $452.3 million. Outside U.S. Segment showed 6.0% growth to $169.8 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.69%
Tags
-
Rhea-AI Summary

Maximus (NYSE: MMS), a government services provider, has announced it will release its financial results for Q1 fiscal 2025, covering the period ended December 31, 2024. The company will publish its financial results via press release at 6:30 a.m. ET on Thursday, February 6, 2025.

A conference call will follow at 9:00 a.m. ET on the same day. The call will be accessible to the public through webcast and phone, with domestic callers using 877.407.8289 and international callers using +1.201.689.8341. A recording of the webcast will be made available on investor.maximus.com for those unable to attend the live call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
conferences earnings
Rhea-AI Summary

Maximus (NYSE: MMS) announced that its subsidiary, Veterans Evaluation Services (VES), has been awarded new contracts by the Veterans Benefit Administration (VBA) to continue providing Medical Disability Exam (MDE) services for domestic Regions 1 through 4. The contracts, effective January 1, 2025, span the continental U.S. and include a one-year base with a single option year, addressing current and anticipated production volumes. These contracts follow a surge in demand that led to the early recompete of Regions 1 through 4. VES has continuously held MDE contracts since 2008 and also services Region 6 Pre-Discharge and Region 7 OCONUS contracts. The MDE program is important for the VBA's Compensation and Pension program, which determines veterans' disability benefits. Maximus' CEO Bruce Caswell and VES Managing Director Rob Nydam expressed pride in their team's dedication and commitment to enhancing veteran services. The VBA has seen a significant increase in disability claims since the 2022 PACT Act, further highlighting the importance of these contracts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
none
-
Rhea-AI Summary

Maximus (NYSE: MMS), a leading provider of government services worldwide, has announced that its Board of Directors approved a quarterly cash dividend of $0.30 per share. The dividend will be payable on February 28, 2025, to shareholders of record on February 15, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
dividends
-
Rhea-AI Summary

Maximus (NYSE:MMS) has announced a $200 million increase to its stock purchase program. The previous authorization of $200 million, announced in June 2024, had $171.4 million available as of September 30, 2024, but recent purchases have exhausted this capacity.

The company will buy shares at market prices, through 10b5-1 plans, or privately negotiated transactions, with the timing and amount of purchases based on market conditions and corporate needs. This program has no expiration date and can be modified or discontinued at any time.

Bruce Caswell, President and CEO, emphasized that this move aligns with their strategy to maximize shareholder value and reflects confidence in their future as a partner to government.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.40%
Tags
none
Rhea-AI Summary

Maximus (NYSE: MMS), a leading government services provider, announced the completion of its divestiture of operations in Australia and South Korea, part of its Outside the U.S. segment. The purchaser, Angus Knight, operates in seven countries, focusing on employment, education, health, and community services. Maximus has been in Australia since 2002 and South Korea since 2020, with over 1,200 employees transitioning to Angus Knight. This move follows prior divestitures in Sweden, Italy, Singapore, and Canada.

According to CEO Bruce Caswell, this transaction aligns with Maximus' strategy to optimize its Outside the U.S. portfolio. The combined annual revenue run-rate for the divested entities was around $120 million, with an estimated $100 million impact on fiscal year 2025 revenue guidance. The transaction is expected to be slightly accretive to fiscal year 2025 adjusted EBITDA margin and adjusted diluted EPS guidance, excluding non-cash foreign exchange losses. The margin outlook for the Outside the U.S. segment is projected to improve to between 3% and 5%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
none
-
Rhea-AI Summary

Maximus (NYSE: MMS) announces that the U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS) has withdrawn their early re-procurement of the Contact Center Operations (CCO) contract for 1-800-MEDICARE and Federal Marketplace services. This decision means Maximus will continue its current contract, which has available option periods until 2031, without having to recompete for the same scope of work. The company currently provides support to more than 75 million eligible Americans who rely on Medicare and the Federal Marketplace.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.54%
Tags
none
-
Rhea-AI Summary

Maximus (NYSE: MMS) announced that the U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services (CMS) has cancelled their Contact Center Operations (CCO) re-procurement solicitation. This cancellation affects the 1-800-MEDICARE and Federal Marketplace operations, which Maximus currently manages. The company will continue providing these services through existing contract option periods available until 2031. The program supports over 75 million eligible Americans who depend on Medicare and the Federal Marketplace.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.54%
Tags
none
Rhea-AI Summary

Maximus (NYSE: MMS) reported strong financial results for fiscal year 2024, with revenue increasing 8.2% to $5.31 billion. Full year diluted earnings per share reached $4.99, with adjusted EPS at $6.11. The company demonstrated solid organic growth of 8.8%, driven by higher volumes in U.S. segments. Operating margin improved to 9.2%, with adjusted EBITDA margin at 11.6%. Cash flows from operations totaled $515 million, with free cash flow of $401 million. The company announced fiscal 2025 guidance with revenue expected between $5.275-$5.425 billion and adjusted diluted EPS of $5.70-$6.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.92%
Tags

FAQ

What is the current stock price of MAXIMUS (MMS)?

MAXIMUS (MMS) last closed at $65.40.

What is the market cap of MAXIMUS (MMS)?

The market cap of MAXIMUS (MMS) is approximately $3.4B.